CAS RN: 22867-74-9
7-Ethylindole
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250509
1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 22867-74-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
22867-74-9 / 7-ethyl-1H-indole
Standard CAS: 22867-74-9
Multi CAS: No
Basic Information
copy
CAS
22867-74-9 copy
Multi CAS
No copy
Molecular Formula
C10H11N copy
Molecular Weight
145.200000 copy
Exact Mass
145.089149 copy
SMILES
CCC1=CC=CC2=C1NC=C2 copy
InChI
InChI=1S/C10H11N/c1-2-8-4-3-5-9-6-7-11-10(8)9/h3-7,11H,2H2,1H3 copy
InChIKey
PIIZLMYXLGYWTN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.2 copy
Rotatable bonds
1 copy
H-bond donors
1 copy
Molar refractivity
47.68 copy
TPSA
15.79 copy
LogP / Solubility
WLOGP
2.73 copy
MLOGP
2.4 copy
XLogP3
3 copy
Consensus LogP
2.71 copy
Log S (ESOL)
-3 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.72 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.99 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.67 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy